PMC:7696151 / 61156-61364
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1754 | 62-70 | Species | denotes | patients | Tax:9606 |
| 1768 | 96-99 | Chemical | denotes | HCQ | MESH:D006886 |
| 1769 | 117-129 | Chemical | denotes | pioglitazone | MESH:D000077205 |
| 1785 | 53-61 | Disease | denotes | diabetic | MESH:D003920 |
| 1786 | 145-153 | Disease | denotes | diabetic | MESH:D003920 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T391 | 0-208 | Sentence | denotes | A randomized double-blind study involving 267 type-2 diabetic patients compared the efficacy of HCQ (400 mg/day) and pioglitazone, a common anti-diabetic drug, in the control of glycemic and lipidic profiles. |